Pharmacological profile of a new orally active growth hormone secretagogue, SM-130686

Journal of Endocrinology

Volumn 171, Issue 3, 2001, Pages 481-489

  Nagamine, J ^a   Nagata, R ^a   Seki, H ^a   Nomura Akimaru, N ^a   Ueki, Y ^a   Kumagai, K ^a   Taiji, M ^a   Noguchi, H ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 DIETHYLAMINOETHYL) 4 TRIFLUOROMETHYL 6 CARBAMOYL 3 HYDROXY 3 (2 CHLOROPHENYL) OXINDOLE; GHRELIN; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; GROWTH HORMONE SECRETAGOGUE; GROWTH HORMONE SECRETAGOGUE RECEPTOR; HEXARELIN; HORMONE ANTAGONIST; IBUTAMOREN; LIGAND; PENTOBARBITAL; RECEPTOR SUBUNIT; SM 130686; SOMATOMEDIN C; SOMATOSTATIN; SULFUR 35; TABIMORELIN; UNCLASSIFIED DRUG;

ANESTHESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; DRUG CONFORMATION; DRUG EFFECT; DRUG RECEPTOR BINDING; FEMALE; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HYPOPHYSIS CELL; IC 50; LIGAND BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; RAT; STRUCTURE ACTIVITY RELATION; WEIGHT GAIN;

ADMINISTRATION, ORAL; ANIMALS; CELL CULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ETHYLAMINES; FEMALE; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; INDOLES; MALE; PEPTIDE HORMONES; PEPTIDES; PITUITARY GLAND, ANTERIOR; RATS; RATS, INBRED F344; RATS, WISTAR; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; WEIGHT GAIN;

EID: 0035668604     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1710481     Document Type: Article

References (29)

1. Comparison of daily versus continuous administration of somatotropin on growth rate, feed intake, and body composition in intact female rats
2. Structure-function studies on the new growth hormone-releasing peptide, ghrelin: Minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a
3. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone
4. The growth hormone-releasing activity of a synthetic hexapeptide in normal men and short statured children after oral administration
5. Growth hormone-releasing peptides and their analogs
6. Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretagogue (MK-677) in healthy elderly subjects
7. Inhibition of L-692, 429-stimulated rat growth hormone release by a weak substance P antagonist: L-756,867
8. Ghrelin: A step forward in the understanding of somatotroph cell function and growth regulation
9. Regulation of growth hormone secretion
10. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues
11. Pharmacological characterisation of a new oral GH secretagogue, NN703
12. Oral administration of growth hormone (GH)-releasing peptide stimulates GH secretion in normal men
13. Effect of sex and age on the 24-hour profile of growth hormone secretion in man: Importance of endogenous estradiol concentrations
14. A receptor in pituitary and hypothalamus that functions in growth hormone release
15. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men
16. Ghrelin is a growth-hormone-releasing acylated peptide from stomach
17. Intracerebroventricular growth-hormone-releasing peptide-6 stimulates eating without affecting plasma growth hormone responses in rats
18. Growth hormone secretagogues: Characterization, efficacy, and minimal bioactive conformation
19. Metabolic effects of growth hormone in humans
20. Determination of body composition in growing rats by total body electrical conductivity
21. Neuroendocrine control of growth hormone secretion
22. Intracerebroventricular administration of the growth hormone-releasing peptide KP-102 increases food intake in free-feeding rats
23. Design and biological activities of L-163,191 (MK-0677): A potent, orally active growth hormone secretagogue
24. Growth hormone, body composition, and aging
25. Oxindole derivatives as orally active potent growth hormone secretagogues
26. Ghrelin induces adiposity in rodents
27. 2 in rats, dogs and monkeys
28. The comparison of several dose levels with a zero dose control
29. The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals